Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

OLUTOLA O ADETONA

Allopathic & Osteopathic Physicians Internal Medicine Hospice and Palliative Medicine

NPI
1164688966
CMS profile
7078
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$6,562.03

30 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $3,450.31 9
Consulting Fee $1,800.00 1
Food and Beverage $1,311.72 20

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Genentech, Inc. $3,419.22 5
Seqirus USA Inc $1,055.07 4
SANOFI PASTEUR INC. $989.24 8
AstraZeneca Pharmaceuticals LP $892.25 7
GlaxoSmithKline, LLC. $114.16 1
Tris Pharma Inc $54.52 3
Greer Laboratories, Inc. $23.09 1
Sarepta Therapeutics, Inc. $14.48 1

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

OLUTOLA O ADETONA

NPI 1164688966 · CMS profile ID 7078

Allopathic & Osteopathic Physicians / Internal Medicine / Hospice and Palliative Medicine

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164688966?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
OLUTOLA O ADETONA, NPI 1164688966, CMS profile ID 7078. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164688966?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). OLUTOLA O ADETONA, NPI 1164688966, CMS profile ID 7078. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164688966?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
OLUTOLA O ADETONA, NPI 1164688966, CMS profile ID 7078, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1164688966?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

30 matching records · $6,562.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 30 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–30 of 30.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Tris Pharma Inc $24.0811/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701602999 CMS
Tris Pharma Inc $16.5308/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701602987 CMS
Seqirus USA Inc $148.5408/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637279377 CMS
Seqirus USA Inc $634.5008/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637279381 CMS
Seqirus USA Inc $160.2108/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637279387 CMS
Seqirus USA Inc $111.8208/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637279373 CMS
AstraZeneca Pharmaceuticals LP $202.2708/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685093589 CMS
AstraZeneca Pharmaceuticals LP $122.2508/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685194893 CMS
AstraZeneca Pharmaceuticals LP $104.6408/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685279351 CMS
AstraZeneca Pharmaceuticals LP $22.6608/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685657851 CMS
AstraZeneca Pharmaceuticals LP $56.7308/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685760527 CMS
AstraZeneca Pharmaceuticals LP $46.0508/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685826123 CMS
AstraZeneca Pharmaceuticals LP $337.6508/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685830407 CMS
SANOFI PASTEUR INC. $389.2405/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600025 CMS
SANOFI PASTEUR INC. $290.0005/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600031 CMS
SANOFI PASTEUR INC. $100.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600037 CMS
SANOFI PASTEUR INC. $30.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600043 CMS
SANOFI PASTEUR INC. $15.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600047 CMS
SANOFI PASTEUR INC. $15.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600053 CMS
SANOFI PASTEUR INC. $50.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691600057 CMS
SANOFI PASTEUR INC. $100.0005/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691645197 CMS
GlaxoSmithKline, LLC. $114.1604/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671493911 CMS
Sarepta Therapeutics, Inc. $14.4803/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681674705 CMS
Tris Pharma Inc $13.9102/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701602885 CMS
Genentech, Inc. $199.0801/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681173541 CMS
Genentech, Inc. $337.8701/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681164459 CMS
Genentech, Inc. $88.3401/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681164773 CMS
Genentech, Inc. $993.9301/24/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681166489 CMS
Genentech, Inc. $1,800.0001/24/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681173743 CMS
Greer Laboratories, Inc. $23.0901/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 675466323 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,562.03 30
PY2021 $238.37 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $21,104.00 1
PY2024 Principal investigator $97.96 1
PY2023 Principal investigator $15,252.93 7
PY2022 Principal investigator $33,617.45 7
PY2021 Principal investigator $80,496.87 17
PY2020 Principal investigator $324,833.30 64
PY2019 Principal investigator $527,849.65 75

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $35.65 12/31/2021 Non-covered Recipient Entity
TEKTON RESEARCH INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY) No dispute reported 06/30/2026 826472163
Principal investigator 1 Merck Sharp & Dohme Corporation $15,213.07 12/31/2021 Non-covered Recipient Entity
BENCHMARK RESEARCH
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age No dispute reported 06/30/2026 848739011
Principal investigator 1 GlaxoSmithKline, LLC. $11,355.16 12/17/2021 Non-covered Recipient Entity
LSB RESEARCH GROUP
A PHASE II, OBSERVER-BLIND, RANDOMIZED, CONTROLLED STUDY TO EVALUATE T No dispute reported 06/30/2026 860871663
Principal investigator 1 SANOFI PASTEUR INC. $2,754.00 12/17/2021 Non-covered Recipient Entity
Lsb Research Group LLC
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants No dispute reported 06/30/2026 838357453
Principal investigator 1 SANOFI PASTEUR INC. $3,300.00 11/29/2021 Non-covered Recipient Entity
Lsb Research Group LLC
PSK0008 Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine (PCV) when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and Infants No dispute reported 06/30/2026 838357447
Principal investigator 1 PFIZER INC. $3,300.00 11/23/2021 Non-covered Recipient Entity
LSB Research GroupLLC dba Benchmark Research
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832639989
Principal investigator 1 PFIZER INC. $15,000.00 09/22/2021 Non-covered Recipient Entity
LSB Research GroupLLC dba Benchmark Research
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832640143
Principal investigator 1 SANOFI PASTEUR INC. $8,000.00 09/03/2021 Non-covered Recipient Entity
Lsb Research Group LLC
PSK0008 Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine (PCV) when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers and Infants No dispute reported 06/30/2026 838357411
Principal investigator 1 Seqirus USA Inc $446.22 06/30/2021 Non-covered Recipient Entity
Tekton Research Inc
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects No dispute reported 06/30/2026 808514615
Principal investigator 1 American Regent $500.00 06/25/2021 Non-covered Recipient Entity
Tekton Research, Inc.
1VIT17044 No dispute reported 06/30/2026 830757435
Principal investigator 1 Genentech, Inc. $1,700.00 04/23/2021 Non-covered Recipient Entity
TEKTON RESEARCH INC
PH III STUDY OF SAFETY EFFICACY OF CAP ENDONUCLEASE IN PEDIATRIC PATIENTS No dispute reported 06/30/2026 836025339
Principal investigator 1 PFIZER INC. $12,250.00 03/19/2021 Non-covered Recipient Entity
Tekton Research Inc
A PHASE 23 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A SARSCOV2 RNA VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PREGNANT WOMEN 18 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832606899
Principal investigator 1 AstraZeneca Pharmaceuticals LP $737.82 03/02/2021 Non-covered Recipient Entity
TEKTON RESEARCH INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY) No dispute reported 06/30/2026 826474797
Principal investigator 1 Cue Health Inc. $2,000.00 02/09/2021 Non-covered Recipient Entity
Health Decisions Inc.
Clinical Study of the Cue Influenza Test with Lay Users Self-Testing in a Simulated Home Use Setting (for 510k submission) No dispute reported 06/30/2026 841490053
Principal investigator 1 PFIZER INC. $698.00 02/05/2021 Non-covered Recipient Entity
Tekton Research Inc
A PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH OR SEPARATELY FROM 13VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 832840389
Principal investigator 1 PFIZER INC. $26.95 01/16/2021 Non-covered Recipient Entity
Tekton Research Inc
A PHASE 2 RANDOMIZED OPENLABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH OR SEPARATELY FROM 13VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS No dispute reported 06/30/2026 832850517
Principal investigator 1 SANOFI PASTEUR INC. $3,180.00 01/12/2021 Non-covered Recipient Entity
Tekton Research,Inc
MET42 Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers No dispute reported 06/30/2026 838363491